Status: Not yet recruiting
A Prospective, Multicenter Trial to Explore the Efficacy and Safety of Obinutuzumab Adds on to Standard-of-care Therapy Consisting of Mycophenolate Mofetil (MMF) and Corticosteroids (O-triple) as Initial Therapy in the Active Lupus Nephritis Patients
This is a prospective single-arm multi-center trial to evaluate the efficacy and safety of O-triple regimen in initial active LN patients
Participants needed: 70
Trial details
Phase: Phase 3Age: 18-65Biological sex: AllType: InterventionalSponsor: Zhao MinghuiUpdated: Aug 17, 2026Locations: 14
Eligibility criteria
Signed Informed Consent Form [+6]
Are pregnant or breastfeeding. [+6]